enormously powerful motivator," explained Hill, adding that he believes it will be the force that drives future participation in phase 0 trials. However, he said he sees nothing ethically objectionable about compensating people for reasonable costs they might incur as participants, such as money spent for travel, food and overnight stays.
The National Cancer Institute does not offer cancer patients financial incentives to participate in trials, Doroshow said.
Study participants also need to be aware that phase 0 trials, like any trial, might involve invasive procedures, such as blood work and biopsies. Before enrolling in a study, people should ask how it might negatively impact them and how it would positively impact others, LoRusso said.
"Some people would say 'no' because they don't want to be a guinea pig, but there are people out there who want to advance the science for future patients if they can," she said.
The U.S. National Cancer Institute has more on phase 0 trials.
SOURCES: James H. Doroshow, M.D., director, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Md.; Patricia M. LoRusso, D.O., director, phase I clinical-pharmacology team, Barbara Ann Karmanos Cancer Institute, and professor, internal medicine, Wayne State University, Detroit; T. Patrick Hill, Ph.D., senior policy fellow, Edward J. Bloustein School of Planning and Public Policy, Rutgers, clinical research ethics consultant, Cancer Institute of New Jersey, New Brunswick, N.J.; Feb 1, 2007, Clinical Cancer Research; April 13, 2009, Journal of Clinical Oncology
Page: 1 2 3 Related medicine news :1
All rights reserved
. Ovation further advances development pipeline with new phase III epilepsy study2
. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial3
. Mannatech Launches Phase One of New Sales and Training Tools4
. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma5
. Manic phase of bipolar disorder benefits from breast cancer medication6
. ARIZONA METH PROJECT Unveils Arizonas Anti-Meth Youth Pledge and Kicks Off Phase Two of Public Awareness Campaign7
. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study8
. Alexza to Initiate the First Phase 3 Trial for AZ-004 (Staccato(R) Loxapine) in Late Q1 20089
. Iomai Patch-Based Vaccine Cut Rate of Travelers Diarrhea by 75 Percent in Phase 2 Field Study10
. MetLife Foundation Begins New Phase of Award-Winning Parenting Skills Campaign in Collaboration with the Partnership for a Drug-Free America(R)11
. Labopharm completes enrolment for Phase III clinical study for its once-daily trazodone antidepressant drug